Christie M Ballantyne Selected Research

LDL Cholesterol

12/2021	Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
12/2021	Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins.
12/2021	Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical Perspective.
9/2021	Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH).
6/2021	Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
1/2021	New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation.
1/2021	What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.
1/2021	Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia.
1/2021	Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation.
1/2021	Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christie M Ballantyne Research Topics

Disease

191	Atherosclerosis 12/2022 - 01/2002
150	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 08/2002
106	Coronary Disease (Coronary Heart Disease) 11/2022 - 03/2003
62	Inflammation (Inflammations) 11/2021 - 01/2002
59	Heart Failure 06/2022 - 04/2010
44	Stroke (Strokes) 01/2022 - 03/2002
38	Hypertension (High Blood Pressure) 01/2022 - 03/2003
37	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 11/2002
37	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020 - 11/2002
35	Hypercholesterolemia 05/2022 - 01/2003
34	Obesity 07/2021 - 06/2004
34	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2002
31	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2003
30	Myocardial Infarction 03/2022 - 11/2008
30	Hypertriglyceridemia 01/2022 - 08/2002
22	Atherosclerotic Plaque (Atheroma) 09/2020 - 04/2006
21	Atrial Fibrillation 01/2022 - 03/2008
21	Insulin Resistance 01/2021 - 05/2004
19	Weight Loss (Weight Reduction) 01/2022 - 06/2004
19	Diabetes Mellitus 01/2020 - 01/2006
17	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 11/2007
16	Ischemic Stroke 11/2022 - 03/2003
16	Acute Coronary Syndrome 01/2021 - 12/2009
14	Peripheral Arterial Disease 01/2021 - 06/2010
10	Infections 03/2021 - 03/2002
9	Chronic Renal Insufficiency 03/2022 - 04/2011
9	Fibrosis (Cirrhosis) 01/2022 - 11/2015
8	Vascular Diseases (Vascular Disease) 01/2021 - 03/2002
7	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 09/2015
7	Hyperlipidemias (Hyperlipidemia) 10/2018 - 08/2002
7	Overweight 01/2017 - 07/2011
6	Renal Insufficiency (Renal Failure) 01/2022 - 01/2009
6	Hyperglycemia 01/2021 - 03/2011
6	Heart Diseases (Heart Disease) 01/2019 - 05/2006
6	Carotid Artery Diseases 01/2019 - 11/2004
5	Neoplasms (Cancer) 01/2022 - 02/2013
5	Kidney Diseases (Kidney Disease) 01/2022 - 01/2015
5	Prediabetic State (Prediabetes) 01/2022 - 10/2014
5	Unstable Angina 11/2021 - 11/2012

Drug/Important Bio-Agent (IBA)

115	LipidsIBA 01/2022 - 03/2002
112	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 01/2002
91	LDL CholesterolIBA 12/2021 - 03/2002
74	oxidized low density lipoproteinIBA 11/2022 - 04/2003
62	Triglycerides (Triacylglycerol)IBA 11/2022 - 03/2002
57	Biomarkers (Surrogate Marker)IBA 08/2022 - 08/2002
57	HDL CholesterolIBA 01/2021 - 11/2002
54	CholesterolIBA 08/2022 - 11/2002
53	C-Reactive ProteinIBA 08/2022 - 07/2003
49	Troponin T (Troponin T1)IBA 03/2022 - 04/2011
36	Atorvastatin (Lipitor)FDA Link 08/2017 - 01/2003
32	pro-brain natriuretic peptide (1-76)IBA 03/2022 - 02/2013
31	Lipoproteins (Lipoprotein)IBA 11/2022 - 11/2002
31	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2022 - 04/2011
31	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2002
28	Ezetimibe (Zetia)FDA Link 12/2021 - 05/2003
27	Rosuvastatin Calcium (Crestor)FDA Link 08/2017 - 01/2003
26	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 03/2002
24	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2022 - 02/2004
24	Simvastatin (Zocor)FDA LinkGeneric 12/2016 - 06/2003
23	eicosapentaenoic acid ethyl esterIBA 01/2022 - 02/2013
23	ApolipoproteinsIBA 01/2021 - 03/2002
19	Lipoprotein(a)IBA 08/2022 - 09/2008
16	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2017 - 03/2003
14	Natriuretic PeptidesIBA 01/2021 - 04/2013
14	HDL LipoproteinsIBA 01/2020 - 03/2002
13	TroponinIBA 06/2022 - 04/2013
13	AdiponectinIBA 08/2015 - 06/2004
12	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 05/2022 - 09/2013
12	Adenosine Triphosphate (ATP)IBA 02/2017 - 11/2002
12	Niacin (Nicotinic Acid)FDA LinkGeneric 07/2011 - 11/2002
11	Insulin (Novolin)FDA Link 01/2017 - 08/2002
10	Galectin 3 (LGALS3)IBA 11/2021 - 01/2016
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2012
9	fenofibric acid FDA Link 06/2014 - 02/2009
8	CalciumIBA 01/2022 - 09/2008
8	Apolipoproteins E (ApoE)IBA 01/2021 - 03/2002
8	IntegrinsIBA 01/2017 - 03/2002
8	Fibric Acids (Fibrates)IBA 06/2014 - 11/2002
7	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 06/2003
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 11/2008
7	Pharmaceutical PreparationsIBA 12/2021 - 03/2003
7	AlbuminsIBA 01/2020 - 04/2011
7	EstersIBA 06/2019 - 07/2007
7	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2008 - 01/2002
6	Troponin IIBA 06/2022 - 01/2019
6	omega-Chloroacetophenone (Mace)IBA 08/2021 - 01/2004
6	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 08/2006
6	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 05/2005
6	evolocumabIBA 09/2020 - 05/2014
6	Apolipoproteins B (ApoB)IBA 01/2019 - 12/2008
6	Blood Glucose (Blood Sugar)IBA 01/2019 - 03/2003
6	Fibrinogen (Factor I)FDA Link 11/2017 - 07/2003
6	Lactic Acid (Lactate)FDA LinkGeneric 02/2015 - 12/2008
6	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2013 - 03/2002
5	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 04/2003
5	Blood Proteins (Serum Proteins)IBA 01/2022 - 05/2008

Therapy/Procedure

116	Therapeutics 11/2022 - 11/2002
8	Secondary Prevention 01/2022 - 01/2004
8	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 01/2011
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2009